US Patent Issued to ALYTAS THERAPEUTICS on Sept. 29 for "Means for specifically eliminating perilipin-1 fragment presenting adipocytes" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,286, issued on Sept. 29, was assigned to ALYTAS THERAPEUTICS GMBH (Jena, Germany).

"Means for specifically eliminating perilipin-1 fragment presenting adipocytes" was invented by Martin Schmidt (Jena, Germany), Cornelius Alfred Rudolf Lemke (Jena, Germany) and Ulrich-Eckehard Baumann (Jena, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an antigen-binding peptide specifically binding to at least one perilipin-1 epitope as defined herein. The present invention further relates to an antigen-binding peptide for use in the prevention or treatment of obesity. Furthermore, the present invention relates to a bispec...